FORMULASI KOMBINASI RIFAMPISIN DAN ARTINM DALAM SISTEM NANOPARTIKEL KITOSAN UNTUK TUJUAN PENGGUNAAN ORAL
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis which can damage many organs, mainly affect the lungs. Rifampicin as the first line of antituberculosis drug has several problems related to its stability, solubility, and bioavailability towards the presence of other...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/44578 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis which can damage
many organs, mainly affect the lungs. Rifampicin as the first line of antituberculosis drug has several
problems related to its stability, solubility, and bioavailability towards the presence of other
antituberculosis drug. Artin-M is a lectin from jackfruit (Artocarpus integrifolia) seeds which has
immunostimulant activities by inducing immune cells with glycosylated receptor on the surface such
as macrophages and dendritic cells to produce cytokines. This study aims to formulate rifampicin along
with artin-M into nanoparticles for oral route of administration by using low molecular weight chitosan
and glucomannan with target of particle size less than 600 nm. Nanoparticles were prepared by ionic
gelation using sodium tripolyphosphate as crosslinking agent (STPP). The formula was optimized to
provide the highest entrapment efficiency of artin-M and rifampicin with appropriate particle size.
Artin-M was adsorbed to glucomannan solution in order to bind specifically, and subsequently
incorporated into nanoparticles. Evaluation of nanoparticles consisted of particle size, polidispersity
index, zeta potential, entrapment efficiency of rifampicin, hemagglutination test and SDS PAGE of
Artin-M. The optimum formula was obtained from 20 mg/mL chitosan at pH 4 with the additions of 6
mg/mL STPP, 10 mg/mL glucomannan, 20% (w/v) polysorbate 80, 1.9 mg/mL artin-M to glucomannan
ratio, 0.75% (w/v) of rifampicin, and at ratio of chitosan : STPP : glucomannan was 5 : 2 : 1. Nanopaticles
were obtained in average particle size of 405.2 ± 7.02 nm, polydispersity index of 0.218 ± 0.006, zeta
potential of +31.65 mV, rifampicin entrapment efficiency of 53.26 ± 0.34%, and hemagglutination test
indicated that 100% of artin-M was entrapped within nanoparticles.
|
---|